Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Polarean Imaging had a gross margin of 53.53% for the quarter that ended in Jun. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Polarean Imaging Gross Margin % Related Terms
Polarean Imaging Gross Margin % Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:POLX vs FOFA, BTCY, LFWD: Gross Margin % Comparison
For the Medical Devices subindustry, Polarean Imaging's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Polarean Imaging (LSE:POLX) has a Gross Margin % of 53.53% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Polarean Imaging and its competitors. This is 16% above median its historical median of 46.05. Over the past decade, Polarean Imaging's Gross Margin % has ranged from 33.69 to 75.99.
Is Polarean Imaging's Gross Margin % too high?
Polarean Imaging's current Gross Margin % of 53.53% is 16% above median its 10-year median of 46.05. Over the past 10 years, this metric has ranged from a low of 33.69 to a high of 75.99. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Polarean Imaging's value of 53.53% is 2.8% above this industry median.
How does Polarean Imaging's Gross Margin % compare to FOFA and BTCY?
Polarean Imaging's Gross Margin % of 53.53% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 52.07. Polarean Imaging's value of 53.53% is 2.8% above this benchmark. Historically, Polarean Imaging's own Gross Margin % has ranged from 33.69 to 75.99 over the past decade. While the company's 10-year median is 46.05 vs. the industry median of 52.07, Polarean Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current Gross Margin % of 53.53% is 2.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Gross Margin % is 53.53%, which is 16% above median its own 10-year median of 46.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (LSE:POLX) has a current Gross Margin % of 53.53%. The current Gross Margin % is 53.53%, which is 16% above median its 10-year median of 46.05 and 2.8% above the Medical Devices & Instruments industry median of 52.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Polarean Imaging (LSE:POLX), the current Gross Margin % is 53.53% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:POLX has been successfully added to your 